Markets opened the week firm, with a wave of fresh analyst calls hitting Monday morning. The Federal Reserve's June 17 decision under new Chair Kevin Warsh held the policy rate at 3.50–3.75% and removed the prior easing bias, and CME FedWatch puts the probability of zero rate cuts in all of 2026 at roughly 80%. M&A activity is tracking to its busiest year since 2007, and the May PCE inflation report due Friday, June 26 is the next macro catalyst. Monday's research notes featured the largest memory price-target raise in years, a rare double-upgrade in autos, and aggressive moves in energy and commercial nuclear. Here are five names where analysts pressed their case in the past two sessions.
Micron Technology (MU) — Bernstein more than doubles the price target
Micron is the U.S.-based memory leader producing DRAM and NAND, with high-bandwidth memory (HBM) for AI accelerators now the franchise's most strategic product line. On June 22, Bernstein raised its price target to $1,300 from $510 while reiterating Outperform, flagging an optimistic outlook on conventional memory and HBM pricing into 2027. The same day, Needham analyst N. Quinn Bolton lifted his Buy target to $1,550 from $500. Stifel's Brian Chin raised his Buy target to $1,500 from $550 on June 18, and Rosenblatt's Kevin Cassidy doubled his Buy target to $1,200 from $600.
Shares trade at $1,199.05, up 5.74% on June 22, with a market cap of $1.35 trillion and a trailing P/E of about 57. The consensus is Strong Buy, with 19 of 20 covering analysts bullish, an average target of $1,313.50, a median of $1,235, and a high of $1,750. Nearly every covering shop has roughly doubled or tripled its target in the past two months, and the new average sits 10% above current price even after a near-12x rally from the $103 52-week low.
Risks: Memory pricing cycles can turn sharply, the trillion-dollar market cap leaves little room for execution missteps, HBM supply discipline depends on Samsung and SK Hynix behavior, and any deceleration in AI accelerator demand would cascade through pricing assumptions.
Visteon (VC) — Double upgrade puts a smart-cockpit name back on the radar
Visteon is a Tier-1 auto supplier focused on digital cockpit electronics, instrument clusters, infotainment, and battery management for EVs. On June 22, JPMorgan analyst Rajat Gupta upgraded the stock from Neutral to Overweight at $165, up from $108, arguing the company is "uniquely positioned to drive outgrowth" with less execution risk than peers. The same morning, Barclays' Dan Levy upgraded to Overweight at $145, up from $115. Wells Fargo's Colin Langan maintains Overweight at $139.
Shares trade at $121.51, up 6.77% on June 22, with a market cap of $3.24 billion and a trailing P/E of 20. The consensus is Strong Buy, with seven of eight covering analysts bullish, an average target of $132.38, a median of $128.50, and a high of $165. The stock sits near its 52-week high of $129.10, and a same-day double upgrade from JPMorgan and Barclays is the kind of confirmation that usually marks a regime change for a small-cap supplier.
Risks: Auto OEM production schedules can swing on tariffs and demand, smart-cockpit content per vehicle assumes continued EV and premium-ICE mix shift, liquidity is thinner than larger suppliers, and any loss of a top-three customer would reset estimates.
Ovintiv (OVV) — Wells Fargo says the portfolio transformation is complete
Ovintiv is an oil and gas E&P with a portfolio anchored in the Permian and Montney basins after several years of repositioning. On June 22, Wells Fargo analyst Hanwen Chang upgraded the stock from Equal-Weight to Overweight at $80, up from $57, arguing the portfolio transformation is complete and the free cash flow profile is not yet reflected in the valuation. Mizuho's Nitin Kumar carries Outperform at $75, and Barclays' Betty Jiang has Overweight at $75.
Shares trade at $54.02, up 3.07% on June 22, with a market cap of $15.2 billion and a trailing P/E of 18. The consensus is Strong Buy, with all 11 covering analysts bullish, an average target of $68, a median of $70, and a high of $80. With the Wells Fargo target representing roughly 48% upside and an unbroken bullish slate from a peer group not known for crowded calls, OVV is the energy name where the analyst dispersion is narrowest.
Risks: WTI crude price assumptions remain the dominant variable, the Iran ceasefire status was described as "tenuous" in Roth's June 22 sector note, hedging programs cap upside in a sharp rally, and capital discipline must hold for the free cash flow thesis to play through.
BWX Technologies (BWXT) — Seaport upgrades on the commercial nuclear acceleration
BWX Technologies supplies U.S. naval nuclear reactors, medical isotopes, and commercial nuclear components, having recently closed the Precision Components Group (PCG) acquisition. On June 22, Seaport upgraded BWXT from Neutral to Buy with a $245 target, raising 2026 guidance after a strong Q1 and citing the PCG deal as establishing manufacturing scale for U.S. commercial nuclear. Deutsche Bank's Scott Deuschle upgraded to Buy at $255 on May 15, and B of A's Ronald Epstein has a Buy at $250.
Shares trade at $211.40, up 2.92% on June 22, with a market cap of $19.4 billion and a trailing P/E of 56. The consensus is Strong Buy, with three of four highest-conviction analysts bullish, an average target of $238, a median of $242.50, and a high of $255. The stock has rallied from a 52-week low of $133.84 toward the 52-week high of $241.82, and Seaport extends a trend of buy-side conversion as commercial SMR orders move from announcements to bookings.
Risks: Naval reactor program timing is set by Department of Defense budgets, commercial SMR revenue is still small in the mix, the P/E already reflects high expectations for nuclear renaissance bookings, and a slowdown in data-center power buildouts would weaken the demand thesis.
Estee Lauder (EL) — Goldman reinstates Buy, calling growth sustainable
Estee Lauder is a global prestige beauty company spanning skincare (La Mer, Estee Lauder), makeup (MAC, Clinique), and fragrance (Tom Ford, Jo Malone). On June 22, Goldman Sachs reinstated coverage with a Buy rating and a $100 price target, arguing the market has not fully recognized the sustainability of growth momentum after a multi-year period of execution challenges. Citigroup's Filippo Falorni maintains Buy at $110, JPMorgan's Andrea Teixeira has Overweight at $99, and RBC's Nik Modi rates it Outperform at $113.
Shares trade at $84.78 with a market cap of $30.7 billion. The trailing P/E is negative on GAAP losses, which is the central debate. The consensus is Buy, with four of 10 covering analysts bullish, six neutral, an average target of $96.50, a median of $94.50, and a high of $115. The stock sits well off the 52-week high of $121.64 against a low of $66.22, and Goldman's reinstatement is the catalyst that converts a turnaround thesis into a near-term call.
Risks: Asia travel retail remains an outsized swing factor, trailing earnings are negative and recovery depends on cost actions sticking, prestige beauty pricing power has not fully reset, and FX headwinds would compress the recovery slope.
Found this helpful? Share it with others.